Beta-L-2'-Deoxy Nucleosides for the Treatment of Hepatitis B

Details for Australian Patent Application No. 2007216721 (hide)

International Classifications

Event Publications

27 September 2007 Application Open to Public Inspection

Published as AU-B-2007216721

27 September 2007 Complete Application Filed

19 May 2011 Application Accepted

Published as AU-B-2007216721

15 September 2011 Standard Patent Sealed

15 March 2012 Assignment Registered

Idenix (Cayman) Limited; Centre National De La Recherche Scientifique; L'Universite Montpellier II The patent has been assigned to Centre National De La Recherche Scientifique; L'Universite Montpellier II; Idenix Pharmaceuticals, Inc.

12 April 2012 Extension of Term of Standard Patents

Centre National De La Recherche Scientifique; L'Universite Montpellier II; Idenix Pharmaceuticals, Inc. The earliest first regulatory approval date provided by the patentee 05 Mar 2007 For the goods SEBIVO telbivudine

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.